Global Non Narcotic Analgesics Market Growth 2025-2031

Publication ID:

LPI01251225

Publication Date:

January 27, 2025

Pages:

101

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Non Narcotic Analgesics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Analgesics mainly work in the central or peripheral nervous system, selective inhibition and relief of a variety of pain, pain relief and fear of tension and anxiety pain drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淣on Narcotic Analgesics Industry Forecast鈥� looks at past sales and reviews total world Non Narcotic Analgesics sales in 2024, providing a comprehensive analysis by region and market sector of projected Non Narcotic Analgesics sales for 2025 through 2031. With Non Narcotic Analgesics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non Narcotic Analgesics industry.
This Insight Report provides a comprehensive analysis of the global Non Narcotic Analgesics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non Narcotic Analgesics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Non Narcotic Analgesics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non Narcotic Analgesics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non Narcotic Analgesics.
This report presents a comprehensive overview, market shares, and growth opportunities of Non Narcotic Analgesics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non Steroid Antiinflammatory Drug
Steroid Antiinflammatory Drug
Segmentation by Application:
Hospital
Medical Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
Reckitt Benckiser
Endo Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non Narcotic Analgesics market?
What factors are driving Non Narcotic Analgesics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non Narcotic Analgesics market opportunities vary by end market size?
How does Non Narcotic Analgesics break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non Narcotic Analgesics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non Narcotic Analgesics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non Narcotic Analgesics by Country/Region, 2020, 2024 & 2031
2.2 Non Narcotic Analgesics Segment by Type
2.2.1 Non Steroid Antiinflammatory Drug
2.2.2 Steroid Antiinflammatory Drug
2.3 Non Narcotic Analgesics Sales by Type
2.3.1 Global Non Narcotic Analgesics Sales Market Share by Type (2020-2025)
2.3.2 Global Non Narcotic Analgesics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Non Narcotic Analgesics Sale Price by Type (2020-2025)
2.4 Non Narcotic Analgesics Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.4.3 Others
2.5 Non Narcotic Analgesics Sales by Application
2.5.1 Global Non Narcotic Analgesics Sale Market Share by Application (2020-2025)
2.5.2 Global Non Narcotic Analgesics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non Narcotic Analgesics Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Non Narcotic Analgesics Breakdown Data by Company
3.1.1 Global Non Narcotic Analgesics Annual Sales by Company (2020-2025)
3.1.2 Global Non Narcotic Analgesics Sales Market Share by Company (2020-2025)
3.2 Global Non Narcotic Analgesics Annual Revenue by Company (2020-2025)
3.2.1 Global Non Narcotic Analgesics Revenue by Company (2020-2025)
3.2.2 Global Non Narcotic Analgesics Revenue Market Share by Company (2020-2025)
3.3 Global Non Narcotic Analgesics Sale Price by Company
3.4 Key Manufacturers Non Narcotic Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non Narcotic Analgesics Product Location Distribution
3.4.2 Players Non Narcotic Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Non Narcotic Analgesics by Geographic Region
4.1 World Historic Non Narcotic Analgesics Market Size by Geographic Region (2020-2025)
4.1.1 Global Non Narcotic Analgesics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non Narcotic Analgesics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non Narcotic Analgesics Market Size by Country/Region (2020-2025)
4.2.1 Global Non Narcotic Analgesics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non Narcotic Analgesics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non Narcotic Analgesics Sales Growth
4.4 APAC Non Narcotic Analgesics Sales Growth
4.5 Europe Non Narcotic Analgesics Sales Growth
4.6 Middle East & Africa Non Narcotic Analgesics Sales Growth
5 Americas
5.1 Americas Non Narcotic Analgesics Sales by Country
5.1.1 Americas Non Narcotic Analgesics Sales by Country (2020-2025)
5.1.2 Americas Non Narcotic Analgesics Revenue by Country (2020-2025)
5.2 Americas Non Narcotic Analgesics Sales by Type (2020-2025)
5.3 Americas Non Narcotic Analgesics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non Narcotic Analgesics Sales by Region
6.1.1 APAC Non Narcotic Analgesics Sales by Region (2020-2025)
6.1.2 APAC Non Narcotic Analgesics Revenue by Region (2020-2025)
6.2 APAC Non Narcotic Analgesics Sales by Type (2020-2025)
6.3 APAC Non Narcotic Analgesics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non Narcotic Analgesics by Country
7.1.1 Europe Non Narcotic Analgesics Sales by Country (2020-2025)
7.1.2 Europe Non Narcotic Analgesics Revenue by Country (2020-2025)
7.2 Europe Non Narcotic Analgesics Sales by Type (2020-2025)
7.3 Europe Non Narcotic Analgesics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non Narcotic Analgesics by Country
8.1.1 Middle East & Africa Non Narcotic Analgesics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non Narcotic Analgesics Revenue by Country (2020-2025)
8.2 Middle East & Africa Non Narcotic Analgesics Sales by Type (2020-2025)
8.3 Middle East & Africa Non Narcotic Analgesics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non Narcotic Analgesics
10.3 Manufacturing Process Analysis of Non Narcotic Analgesics
10.4 Industry Chain Structure of Non Narcotic Analgesics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non Narcotic Analgesics Distributors
11.3 Non Narcotic Analgesics Customer
12 World Forecast Review for Non Narcotic Analgesics by Geographic Region
12.1 Global Non Narcotic Analgesics Market Size Forecast by Region
12.1.1 Global Non Narcotic Analgesics Forecast by Region (2026-2031)
12.1.2 Global Non Narcotic Analgesics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non Narcotic Analgesics Forecast by Type (2026-2031)
12.7 Global Non Narcotic Analgesics Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Information
13.1.2 Sanofi S.A. Non Narcotic Analgesics Product Portfolios and Specifications
13.1.3 Sanofi S.A. Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi S.A. Main Business Overview
13.1.5 Sanofi S.A. Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Non Narcotic Analgesics Product Portfolios and Specifications
13.2.3 Novartis AG Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GlaxoSmithKline PLC
13.3.1 GlaxoSmithKline PLC Company Information
13.3.2 GlaxoSmithKline PLC Non Narcotic Analgesics Product Portfolios and Specifications
13.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline PLC Main Business Overview
13.3.5 GlaxoSmithKline PLC Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Non Narcotic Analgesics Product Portfolios and Specifications
13.4.3 Pfizer Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Reckitt Benckiser
13.5.1 Reckitt Benckiser Company Information
13.5.2 Reckitt Benckiser Non Narcotic Analgesics Product Portfolios and Specifications
13.5.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Reckitt Benckiser Main Business Overview
13.5.5 Reckitt Benckiser Latest Developments
13.6 Endo Pharmaceuticals
13.6.1 Endo Pharmaceuticals Company Information
13.6.2 Endo Pharmaceuticals Non Narcotic Analgesics Product Portfolios and Specifications
13.6.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Endo Pharmaceuticals Main Business Overview
13.6.5 Endo Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂